AstraZeneca Plans to Begin Selling COVID-19 Vaccines at Profit

An office of British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca is seen in Cheshire, England in a file photograph. Paul Ellis/AFP via Getty Images

Pharmaceutical company AstraZeneca, which said it would not take a profit from its COVID-19 vaccines during the pandemic, has now unveiled plans to start selling the shots at “modest profitability.”

In its latest financial results published on Friday, AstraZeneca said it is now “expecting to progressively transition the vaccine to modest profitability as new orders are received.”